Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier.
暂无分享,去创建一个
Satoru Hayasaka | Youngkyoo Jung | Anirudh Sattiraju | S. Hayasaka | Youngkyoo Jung | A. Mintz | Akiva Mintz | King C P Li | King C. Li | Yao Sun | Xiaobing Xiong | Yao Sun | Anirudh Sattiraju | Xiao-Bing Xiong
[1] R. Edwards. Drug delivery via the blood–brain barrier , 2001, Nature Neuroscience.
[2] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[3] V. Šubr,et al. Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[4] S. Libutti,et al. Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect , 2007, Clinical Cancer Research.
[5] J. Karp,et al. Mesenchymal stem cell therapy: Two steps forward, one step back. , 2010, Trends in molecular medicine.
[6] K. Hynynen,et al. MRI-guided disruption of the blood-brain barrier using transcranial focused ultrasound in a rat model. , 2012, Journal of Visualized Experiments.
[7] C. Moonen,et al. Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters. , 2005, Methods.
[8] Jeremy P. Sauer,et al. Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles , 2014, Nature Medicine.
[9] S. Guccione,et al. Use of in vivo bioluminescence and MRI to determine hyperthermia‐induced changes in luciferase activity under the control of an hsp70 promoter , 2012, NMR in biomedicine.
[10] B. Cornelissen,et al. Selective Permeabilization of the Blood–Brain Barrier at Sites of Metastasis , 2013, Journal of the National Cancer Institute.
[11] H. Lei,et al. Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis , 2001 .
[12] Kullervo Hynynen,et al. Ultrasound enhanced drug delivery to the brain and central nervous system , 2012, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[13] M. Prados,et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. , 2003, Neuro-oncology.
[14] M. Kerin,et al. Advances in mesenchymal stem cell-mediated gene therapy for cancer , 2010, Stem Cell Research & Therapy.
[15] J. Nutt,et al. Strategies to advance translational research into brain barriers , 2008, The Lancet Neurology.
[16] A. Bahrami,et al. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy , 2015, Cell biology international.
[17] Mehmet Fatih Yanik,et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. , 2013, Blood.
[18] Charles A. Gersbach,et al. Light-Inducible Spatiotemporal Control of Gene Activation by Customizable Zinc Finger Transcription Factors , 2012, Journal of the American Chemical Society.
[19] E. Neuwelt,et al. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. , 1998, Neurosurgery.
[20] S. Kang,et al. Journey of Mesenchymal Stem Cells for Homing: Strategies to Enhance Efficacy and Safety of Stem Cell Therapy , 2012, Stem cells international.
[21] F. Lejeune,et al. High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer. , 1995, European journal of cancer.
[22] D. Robertson,et al. Pharmacological Modification of Bradykinin Induced Breakdown of the Blood-brain Barrier , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[23] Kenneth R Diller,et al. Stress protein expression kinetics. , 2006, Annual review of biomedical engineering.
[24] K. Shah. Mesenchymal stem cells engineered for cancer therapy. , 2012, Advanced drug delivery reviews.
[25] W. Pardridge. The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.
[26] R M Henkelman,et al. Ex vivo tissue‐type independence in proton‐resonance frequency shift MR thermometry , 1998, Magnetic resonance in medicine.
[27] J. de Vellis,et al. Stem cell‐based cell therapy in neurological diseases: A review , 2009, Journal of neuroscience research.
[28] M. Fukui,et al. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. , 1996, Neurosurgery.
[29] Weian Zhao,et al. Mesenchymal Stem Cell Biodistribution, Migration, and Homing In Vivo , 2014, Stem cells international.
[30] S. Rapoport. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy , 2001, Expert opinion on investigational drugs.
[31] C. Moonen,et al. Image-guided, noninvasive, spatiotemporal control of gene expression , 2009, Proceedings of the National Academy of Sciences.
[32] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[33] F. Jolesz,et al. Magnetic resonance-guided focused ultrasound: a new technology for clinical neurosciences. , 2014, Neurologic clinics.
[34] K. Hynynen,et al. Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. , 2012, Neurosurgical focus.
[35] F. Balkwill. Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.
[36] M. Andreeff,et al. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.
[37] P. Black,et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Bynoe,et al. Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier , 2011, The Journal of Neuroscience.
[39] D. Fortin,et al. Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy , 2008, The AAPS Journal.
[40] S. Rapoport,et al. Tight‐Junctional Modification as the Basis of Osmotic Opening of the Blood‐Brain Barrier a , 1986, Annals of the New York Academy of Sciences.
[41] K. Hynynen,et al. Trans-skull ultrasound therapy: the feasibility of using image-derived skull thickness information to correct the phase distortion , 1999, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[42] J. Segovia,et al. Transmigration of Neural Stem Cells across the Blood Brain Barrier Induced by Glioma Cells , 2013, PloS one.
[43] Jeffrey M Karp,et al. Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.
[44] Kullervo Hynynen,et al. Ultrasound for drug and gene delivery to the brain. , 2008, Advanced drug delivery reviews.
[45] C. Moonen,et al. Combination of cell delivery and thermoinducible transcription for in vivo spatiotemporal control of gene expression: a feasibility study. , 2011, Radiology.
[46] K. Hynynen,et al. MRI investigation of the threshold for thermally induced blood–brain barrier disruption and brain tissue damage in the rabbit brain , 2004, Magnetic resonance in medicine.
[47] G. Daley,et al. The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.
[48] A. Di Stefano,et al. Designing prodrugs for the treatment of Parkinson's disease , 2012, Expert opinion on drug discovery.
[49] Randall J. Platt,et al. Optical Control of Mammalian Endogenous Transcription and Epigenetic States , 2013, Nature.
[50] S. Gambardella,et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. , 2010, International journal of clinical and experimental medicine.
[51] S. Maier,et al. MAGNETIC RESONANCE IMAGING‐GUIDED, HIGH‐INTENSITY FOCUSED ULTRASOUND FOR BRAIN TUMOR THERAPY , 2006, Neurosurgery.
[52] Z. Qin,et al. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. , 1999, Brain research. Molecular brain research.
[53] Thomas Knobloch,et al. Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB) , 2011, Journal of drug targeting.
[54] X. Wu,et al. Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.